Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2026 FYStats. 
Home
Equities
GLUE
Fundamentals

Monte Rosa Therapeutics, Inc.

GLUE

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

459.84M
▲100.26M▲27.88%
3 Months Change

Liabilities

214.00M
▲122.50M▲133.87%
3 Months Change

Free Cash Flow

-47.08M
▼-7.53M▼-19.04%
12 Months Change

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2026-02-10
Form 8-K
ID: 0001193125-26-044616
2026-01-09
Form 8-K
ID: 0001193125-26-009005
2026-01-07
Form 8-K
ID: 0001193125-26-006341
2026-01-07
Form 8-K
ID: 0001193125-26-005420
2025-12-16
Form 8-K
ID: 0001193125-25-319981
2025-11-06
Form 10-Q
ID: 0001193125-25-268045
2025-11-06
Form 8-K
ID: 0001193125-25-268042
2025-09-15
Form 8-K
ID: 0001193125-25-202760
2025-08-07
Form 10-Q
ID: 0000950170-25-104550
2025-08-07
Form 8-K
ID: 0000950170-25-104545